View Item 

Show simple item record

Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016
dc.contributor.authorBrett, Jonathan
dc.contributor.authorMaust, Donovan T.
dc.contributor.authorBouck, Zach
dc.contributor.authorIgnacio, Rosalinda V.
dc.contributor.authorMecredy, Graham
dc.contributor.authorKerr, Eve A.
dc.contributor.authorBhatia, Sacha
dc.contributor.authorElshaug, Adam G.
dc.contributor.authorPearson, Sallie A.
dc.date.accessioned2018-08-13T18:52:17Z
dc.date.available2019-09-04T20:15:38Zen
dc.date.issued2018-07
dc.identifier.citationBrett, Jonathan; Maust, Donovan T.; Bouck, Zach; Ignacio, Rosalinda V.; Mecredy, Graham; Kerr, Eve A.; Bhatia, Sacha; Elshaug, Adam G.; Pearson, Sallie A. (2018). "Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016." Journal of the American Geriatrics Society 66(6): 1180-1185.
dc.identifier.issn0002-8614
dc.identifier.issn1532-5415
dc.identifier.urihttps://hdl.handle.net/2027.42/145359
dc.publisherVA Office of Mental Health Operations
dc.publisherWiley Periodicals, Inc.
dc.subject.otherUnited States
dc.subject.otherbenzodiazepines
dc.subject.otherChoosing Wisely
dc.subject.otherAustralia
dc.subject.otherOntario
dc.subject.otherolder adults
dc.titleBenzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelGeriatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145359/1/jgs15292.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145359/2/jgs15292_am.pdf
dc.identifier.doi10.1111/jgs.15292
dc.identifier.sourceJournal of the American Geriatrics Society
dc.identifier.citedreferenceMaust D, Blow F, Wiechers I, Kales H, Marcus S. National trends in antidepressant, benzodiazepine, and other sedative‐hypnotic treatment of older adults in psychiatric and primary care. J Clin Psychiatry 2017; 78: e363.
dc.identifier.citedreferenceMaree RD, Marcum ZA, Saghafi E, Weiner DK, Karp JF. A systematic review of opioid and benzodiazepine misuse in older adults. Am J Geriatr Psychiatry 2016; 24: 949 – 963.
dc.identifier.citedreferenceCampanelli CM. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc 2012; 60: 616.
dc.identifier.citedreferenceGallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Therapeut 2008; 46: 72 – 83.
dc.identifier.citedreferenceLevinson W. Searching for effective innovations I: Reducing low‐value care. Webinar. Washington: Academy of Health; 2015 [on‐line]. Available at http://www.academyhealth.org/Events/events.cfm?ItemNumber=16876 Accessed July 2017.
dc.identifier.citedreferenceCanadian Geriatrics Society. Five Things Physicians and Patients Should Question 2014 [on‐line]. Available at http://www.choosingwiselycanada.org/recommendations/geriatrics/ Accessed July 2017.
dc.identifier.citedreferenceCanadian Psychiatric Association. Thirteen Things Physicians and Patients Should Question 2015 [on‐line]. Available at http://www.choosingwiselycanada.org/recommendations/psychiatry/ Accessed July 2017.
dc.identifier.citedreferenceAmerican Geriatrics Society. Ten Things Clinicians and Patients Should Question 2015 [on‐line]. Available at http://www.choosingwisely.org/societies/american-geriatrics-society/ Accessed July 2017.
dc.identifier.citedreferenceAustralia and New Zealand Society for Geriatric Medicine. Five Things Physicians and Patients Should Question 2016 [on‐line]. Available at http://www.choosingwisely.org.au/recommendations/anzsgm Accessed July 2017.
dc.identifier.citedreferenceMaust DT, Kales HC, Wiechers IR, Blow FC, Olfson M. No end in sight: Benzodiazepine use in older adults in the United States. J Am Geriatr Soc 2016; 64: 2546 – 2553.
dc.identifier.citedreferenceOlfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry 2015; 72: 136 – 142.
dc.identifier.citedreferenceIslam M, Conigrave K, Day C, Nguyen Y, Haber P. Twenty‐year trends in benzodiazepine dispensing in the Australian population. Intern Med J 2014; 44: 57 – 64.
dc.identifier.citedreferenceIaboni A, Bronskill SE, Reynolds KB et al. Changing pattern of sedative use in older adults: A population‐based cohort study. Drugs Aging 2016; 33: 523 – 533.
dc.identifier.citedreferenceHuerta C, Abbing‐Karahagopian V, Requena G et al. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: A cross‐national descriptive study from the PROTECT‐EU Project. Pharmacoepidemiol Drug Saf 2016; 25Suppl1: 56 – 65.
dc.identifier.citedreferenceMellish L, Karanges EA, Litchfield MJ et al. The Australian Pharmaceutical Benefits Scheme data collection: A practical guide for researchers. BMC Res Notes 2015; 8: 634.
dc.identifier.citedreferenceKales HC, Zivin K, Kim HM et al. Trends in antipsychotic use in dementia 1999–2007. Arch Gen Psychiatry 2011; 68: 190 – 197.
dc.identifier.citedreferenceGomes T, Juurlink D, Yao Z et al. Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: A time series analysis. Can Med Assoc J Open 2014; 2: E256 – E261.
dc.identifier.citedreferenceBachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. Am J Public Health 2016; 106: 686 – 688.
dc.identifier.citedreferenceWiechers IR HR, Katz I. Psychotropic Drug Safety Initiative: Phase 1. Evaluation of Impact. Northeast Program Evaluation Center. West Haven, CT: VA Office of Mental Health Operations, 2016.
dc.identifier.citedreferenceBrett J KE, Daniels B, Buckley NA et al. Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure. Aust N Z J Psychiatry 2017; 51: 990 – 999.
dc.identifier.citedreferenceWestbury J, Tichelaar L, Peterson G, Gee P, Jackson S. A 12‐month follow‐up study of “RedUSe”: A trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. International Psychogeriatrics 2011; 23: 1260 – 1269.
dc.identifier.citedreferenceSiriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M. GPs’ attitudes to benzodiazepine and ‘Z‐drug’ prescribing: A barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 2006; 56: 964 – 967.
dc.identifier.citedreferenceCook JM, Marshall R, Masci C, Coyne JC. Physicians’ perspectives on prescribing benzodiazepines for older adults: A qualitative study. J Gen Intern Med 2007; 22: 303 – 307.
dc.identifier.citedreferenceMah L, Upshur RE. Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions. BMC Fam Pract 2002; 3: 9.
dc.identifier.citedreferenceLamberg L. Despite effectiveness, behavioral therapy for chronic insomnia still underused. JAMA 2008; 300: 2474 – 2475.
dc.identifier.citedreferencePaulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med 2011; 12: 747 – 754.
dc.identifier.citedreferenceBrett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr 2015; 38: 152.
dc.identifier.citedreferenceHollingworth SA, Siskind DJ. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf 2010; 19: 280 – 288.
dc.identifier.citedreferenceTannenbaum C, Paquette A, Hilmer S, Holroyd‐Leduc J, Carnahan R. A systematic review of amnestic and non‐amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 2012; 29: 639 – 658.
dc.identifier.citedreferencePalmaro A, Dupouy J, Lapeyre‐Mestre M. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 2015; 25: 1566 – 1577.
dc.identifier.citedreferenceWagner AK, Zhang F, Soumerai SB et al. Benzodiazepine use and hip fractures in the elderly: Who is at greatest risk? Arch Intern Med 2004; 164: 1567 – 1572.
dc.identifier.citedreferenceLader M. Benzodiazepines revisited—will we ever learn? Addiction 2011; 106: 2086 – 2109.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgs15292.pdf
Size:
338.7KB
Format:
PDF
View/Open
Name:
jgs15292_am.pdf
Size:
353.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.